Dr. Emma Ramnarine is an accomplished senior leader with 23+ years of global experience in the pharmaceutical, biotech and medical device industries in Analytical Science & Technology, Product Management, Outsourcing & External Collaborations, Risk Management, QC and Quality Management Systems. Emma is Head of Product Management & Development Operations for US Operations at Boehringer Ingelheim. Prior to this she was at Genentech Roche for 17 years in various global roles in Product Development, Quality, QC and Analytical Sciences.
Emma is a purpose-driven leader and a catalyst for change, passionate about making a meaningful difference for patients and public health. She currently Co-leads the Industry One-Voice-of-Quality (1VQ) Initiative on Post Approval Changes, and is a well-recognized industry thought leader and expert on QRM, and Quality Management Systems.
Emma is an officer and has been on the PDA Board of Directors for 8 years. She holds a PhD in Pharmaceutical Sciences from TU Dublin, an M.S. in Pharmaceutical Sciences from University of Connecticut, an M. Pharm. and a B. Pharm., both from University of Indore, India, and an Executive Business Education Certificate from Stanford University.